Challenges to Biosimilar Substitution-Reply

JAMA. 2017 Sep 26;318(12):1186-1187. doi: 10.1001/jama.2017.11937.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Biosimilar Pharmaceuticals*
  • Drug Approval*
  • Humans

Substances

  • Biosimilar Pharmaceuticals